CompanyESLA ESLAWNasdaqEmeryville, CA

Estrella Immunopharma, Inc.

Estrella Immunopharma develops T-cell therapies for cancers and autoimmune diseases using its ARTEMIS platform.

SEC EDGAR ClinicalTrials.gov

8-KOct 29Latest SEC filing

Oct 29Latest story

October 2026

Estrella Immunopharma names Cynthia Pussinen CEO and board chair

Oct 29PeopleEstrella Immunopharma, Inc.